References
- 1. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19.
- 2. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004;363: 1965-76.
- 3. Tse W, Cersosimo MG, Gracies JM, Morgello S, Olanow CW, Koller W. Movement disorders and AIDS: a review. Parkinsonism Relat Disord. 2004;10:323-34.
- 4. Cardoso F. HIV-related movement disorders: epidemiology, pathogenesis and management. CNS Drugs. 2002;16:663-8.
- 5. Rosso AL, Mattos JP, Correa RB, Nicaretta DH, Novis SA. Parkinsonism and AIDS: a clinical comparative study before and after HAART. Arq Neuropsiquiatr. 2009;67:827-30.
- 6. Brew BJ, Crowe SM, Landay A, et al. Neurodegeneration and ageing in the HAART era. J Neuroimmune Pharmacol. 2009;4:163-74.
- 7. Factor SA, Troche-Panetto M, Weaver SA. Dystonia in AIDS: report of four cases. Mov Disord. 2003;18:1492-8.
- 8. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, et al. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS ONE. 2011;6(9):e23866.
- 9. Miman O, Kusbeci OY, Aktepe OC, Cetinkaya Z. The probable relation between Toxoplasma gondii and Parkinson’s disease. Neurosci Lett. 2010;475:129-31.
- 10. Szewczyk-Krolikowski K, Tomlinson P, Nithi K, et al. The influence of age and gender on motor and non-motor features of early Parkinson’s disease: initial findings from the Oxford Parkinson Disease Center (OPDC) discovery cohort. Parkinsonism Relat Disord. 2014;20:99-105.